Literature DB >> 3265514

Genetic analysis of immunocompetence measures in a White Leghorn chicken line.

S Cheng1, S J Lamont.   

Abstract

Immunocompetence of the Iowa State University S1 White Leghorn chicken line was studied. This line was divided into eight sublines based upon erythrocyte antigen B (Ea-B) allele (B1B1 or B19B19), antibody response to glutamic acid60-alanine30-tyrosine10 (GAT) (high or low), and response to Rous sarcoma virus-induced tumors (progression or regression). Antibody responses to Pasteurella multocida (PM), Mycoplasma gallisepticum (MG), and infectious bursal disease virus vaccines were evaluated by enzyme-linked immunosorbent assay. Phagocytic activity and T cell-mediated response were measured by carbon clearance and phytohemagglutinin (PHA) injection assays, respectively. Significant haplotype (subline) differences and sire family differences were observed in all three measurements. Significant sex differences were observed in phagocytic activity and T cell-mediated responses. Haplotypes with high antibody responses to GAT had significantly higher antibody titers to PM and MG vaccines than haplotypes with low antibody responses. Significant positive correlations were observed between antibody levels to the two vaccines. A significant negative correlation was seen between phagocytic activity and T cell-mediated response of females. The data suggest that the total immunocompetence profile of an individual must be considered to select for optimum immune responsiveness.

Entities:  

Mesh:

Year:  1988        PMID: 3265514     DOI: 10.3382/ps.0670989

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  16 in total

1.  Density-dependent competition and selection on immune function in genetic lizard morphs.

Authors:  E Svensson; B Sinervo; T Comendant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

2.  Cross-fostering reveals an effect of spleen size and nest temperatures on immune responses in nestling European starlings.

Authors:  Daniel R Ardia
Journal:  Oecologia       Date:  2005-10-25       Impact factor: 3.225

3.  Cell-mediated immunosenescence in birds.

Authors:  Mark F Haussmann; David W Winkler; Charles E Huntington; David Vleck; Carrie E Sanneman; Daniel Hanley; Carol M Vleck
Journal:  Oecologia       Date:  2005-10-25       Impact factor: 3.225

4.  Parasites shape the optimal investment in immunity.

Authors:  Barbara Tschirren; Heinz Richner
Journal:  Proc Biol Sci       Date:  2006-07-22       Impact factor: 5.349

5.  An Mhc class I allele associated to the expression of T-dependent immune response in the house sparrow.

Authors:  Camille Bonneaud; Murielle Richard; Bruno Faivre; Helena Westerdahl; Gabriele Sorci
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

6.  Immunotoxic effect of thiamethoxam in immunized mice with Brucella abortus cultural filtrate antigen.

Authors:  L H Salema; M J Alwan; Afaf Abdulrahman Yousif
Journal:  Vet World       Date:  2016-12-13

7.  Phenotypes including immunocompetence in scavenging local chicken ecotypes in Tanzania.

Authors:  P L Msoffe; U M Minga; J E Olsen; M G Yongolo; H R Juul-Madsen; P S Gwakisa; M M Mtambo
Journal:  Trop Anim Health Prod       Date:  2001-07       Impact factor: 1.559

8.  Pheasant sexual ornaments reflect nutritional conditions during early growth.

Authors:  Thomas Ohlsson; Henrik G Smith; Lars Råberg; Dennis Hasselquist
Journal:  Proc Biol Sci       Date:  2002-01-07       Impact factor: 5.349

9.  Inbreeding depresses immune response in song sparrows (Melospiza melodia): direct and inter-generational effects.

Authors:  Jane M Reid; Peter Arcese; Lukas F Keller
Journal:  Proc Biol Sci       Date:  2003-10-22       Impact factor: 5.349

10.  Nestling immune response to phytohaemagglutinin is not heritable in collared flycatchers.

Authors:  Natalia Pitala; Lars Gustafsson; Joanna Sendecka; Jon E Brommer
Journal:  Biol Lett       Date:  2007-08-22       Impact factor: 3.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.